Synthesis, In Vitro Evaluation, Molecular Docking and DFT Studies of Some Phenyl Isothiocyanates as Anticancer Agents

被引:5
|
作者
Richa, Kikoleho [1 ,2 ]
Karmaker, Rituparna [1 ]
Longkumer, Naruti [1 ]
Das, Vishal [3 ]
Bhuyan, Pulak J. [4 ]
Pal, Mintu [3 ]
Sinha, Upasana B. [1 ]
机构
[1] Nagaland Univ, Dept Chem, Lumami 798627, Nagaland, India
[2] Nagaland Univ, Bioinformat Facil Ctr, Lumami 798627, Nagaland, India
[3] Acad Sci & Innovat Res, CSIR NEIST, Biotechnol Grp, Biol Sci & Technol Div, Jorhat 785006, Assam, India
[4] CSIR NEIST, Chem Sci & Technol Div, Jorhat 785006, Assam, India
关键词
Synthesis; isothiocyanates; anticancer; in vitro; in silico; band gap energy; SPINDLIN1; DRUG; INHIBITORS; OVEREXPRESSION; IDENTIFICATION; PREDICTION; CHEMISTRY; DESIGN;
D O I
10.2174/1871520619666190930122137
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Isothiocyanates (ITCs) are small molecules that are important in synthetic organic chemistry, but their actual importance ties in their potential as anti-carcinogens. Through this piece of work, an effort was made to assess the anti-cancer activity of some simple ITCs which can be synthesized through easy greener pathways. Methods: Cell proliferation assay was performed on ovarian cancer cells (PA-1) and non-tumorigenic ovarian epithelial cells (IOSE-364). Furthermore, qRT-PCR for transcript expression levels of Spindlin1 and caspases in ovarian cancer cells and cell cycle analysis was performed. In silico studies were incorporated to understand the mode of ligand-protein interaction, ADME/Toxicity and drug-likeliness parameters. Density functional theory studies have been also been employed on the ITCs to assess their efficiency in anticancer activity. Results: An inexpensive, environmentally benign pathway has been developed for synthesizing a series of ITCs. Among the synthesized ITCs, NC6 showed better cytotoxic effects as compared to its counterparts. Novel findings revealed that NC6 had 5-folds lower transcript expression levels of Spindlin1 and induced caspases 3 and 7 expressions assessed by qRT-PCR in ovarian cancer cells. Furthermore, flow cytometry assay showed the cell cycle arrest at G(1)/S phase of cell cycle. The molecular docking studies revealed favorable binding affinities and the physiochemical parameters were predicted to be compatible with drug-likeliness. Conclusion: The results demonstrated the possibility that small isothiocyanate molecules which can be synthesized by a simple green methodology, can pose as promising candidates for their application as anticancer agents.
引用
收藏
页码:2211 / 2222
页数:12
相关论文
共 50 条
  • [1] Synthesis, biological evaluation and molecular docking studies of some novel indenospiro derivatives as anticancer agents
    Patravale, Ajinkya A.
    Gore, Anil H.
    Kolekar, Govind B.
    Deshmukh, Madhukar B.
    Choudhari, Prafulla B.
    Bhatia, Manish S.
    Prabhu, Shivadatta
    Jamdhade, Mahendra D.
    Patole, Milind S.
    Anbhule, Prashant V.
    JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2016, 68 : 105 - 118
  • [2] Synthesis and characterization of novel thiazole derivatives as potential anticancer agents: Molecular docking and DFT studies
    Raveesha, R.
    Anusuya, A. M.
    Raghu, A. V.
    Kumar, K. Yogesh
    Kumar, M. G. Dileep
    Prasad, S. B. Benaka
    Prashanth, M. K.
    COMPUTATIONAL TOXICOLOGY, 2022, 21
  • [3] Synthesis and in vitro Antiproliferative Evaluation and Molecular Docking Studies of Novel Chalcone-Phosphonates Derivatives as Anticancer Agents
    Mishra, Shweta
    Verma, Ekta
    Debnath, Biplab
    Chawla, Amit
    Shama Khandige, Prasanna
    Saxena, Bhagawati
    Sahoo, Nityananda
    Jana, Pardip
    CHEMISTRYSELECT, 2024, 9 (23):
  • [4] Synthesis of combretastatin analogs: evaluation of in vitro anticancer activity and molecular docking studies
    Sunil Kumar
    Sameer Sapra
    Raj Kumar
    Manish Kumar Gupta
    Surrinder Koul
    Tandeep Kour
    Ajit Kumar Saxena
    Om Prakash Suri
    Kanahya Lal Dhar
    Medicinal Chemistry Research, 2012, 21 : 3720 - 3729
  • [5] Synthesis of combretastatin analogs: evaluation of in vitro anticancer activity and molecular docking studies
    Kumar, Sunil
    Sapra, Sameer
    Kumar, Raj
    Gupta, Manish Kumar
    Koul, Surrinder
    Kour, Tandeep
    Saxena, Ajit Kumar
    Suri, Om Prakash
    Dhar, Kanahya Lal
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (11) : 3720 - 3729
  • [6] Synthesis, in vitro Cytotoxicity Evaluation, and Docking Studies of Gloriosine Derivatives as Potential Anticancer Agents
    Goel, Bharat
    Naik, Aliva
    Tripathi, Nancy
    Khan, Anjesh
    Bansal, Sunil
    Bansal, Shivani
    Guru, Santosh Kumar
    Jain, Shreyans K.
    CHEMISTRYSELECT, 2023, 8 (32):
  • [7] Synthesis, biological evaluation and molecular docking studies of some novel cyclopropane carbohydrazide derivatives as potential anticancer agents
    Swamy, Ponnapalli Veerabhadra
    Kambhampati, Pullaiah China
    Chandrasekhar, Kothapalli Bonnoth
    Thirupathi, Gugulothu
    Sujitha, Pombala
    Kumar, Chityal Ganesh
    Kumar, Veeramachaneni Ganesh
    JOURNAL OF CHEMICAL SCIENCES, 2016, 128 (06) : 929 - 939
  • [8] Synthesis, biological evaluation and molecular docking studies of some novel cyclopropane carbohydrazide derivatives as potential anticancer agents
    PONNAPALLI VEERABHADRA SWAMY
    PULLAIAH CHINA KAMBHAMPATI
    KOTHAPALLI BONNOTH CHANDRASEKHAR
    GUGULOTHU THIRUPATHI
    POMBALA SUJITHA
    CHITYAL GANESH KUMAR
    VEERAMACHANENI GANESH KUMAR
    Journal of Chemical Sciences, 2016, 128 : 929 - 939
  • [9] Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents
    Ashmawy, Fayza O.
    Gomha, Sobhi M.
    Abdallah, Magda A.
    Zaki, Magdi E. A.
    Al-Hussain, Sami A.
    El-desouky, Mohamed A.
    MOLECULES, 2023, 28 (11):
  • [10] Synthesis, Molecular Docking Studies, and In vitro Anticancer Evaluation of Novel Tolfenamic Acid Derivatives
    Mehihi, Abbas A. A.
    Kubba, Ammar A. A.
    Tahtamouni, Lubna H. H.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2023, 20 (09) : 1393 - 1413